Accordingly, in RA patients, mitochondrial ROS correlates with elevated levels of TNFα in plasma [9] and TNF blocking therapy suppresses oxidative stress and hypoxia-induced mitochondrial mutagenesis as well as recovery of disease evaluated with DAS28 score [10]. Here, TNF is linked to rheumatoid arthritis.